STIC Investments Inc. is one of the largest and most experienced private equity firms in Korea, founded in 1999. The firm seeks to create growth and prosperity across Asia through private equity, venture capital, growth capital, buyout, and special situation investments, with subsidiaries including STIC Ventures and STIC Alternative.
Deal activity increased 50% year-over-year (3 deals in the last 12 months). Average disclosed round size is $719.8M (across 44 rounds with reported amounts).
Portfolio
50
Fund Size
—
Top Stage
Series A
Last 12 Mo
3
Team
AN, Joon Ha
Managing Partner Private Equity/Partners Committee Seoul
CHAI, Jin Ho
Executive Managing Partner Head of Private Equity Private Equity/Partners Committee Seoul
CHO, Jason
Managing Partner Private Equity/Partners Committee Seoul
CHO, Young-Min
Managing Partner Growth Capital/Partners Committee Seoul
KANG, Il Sung
Managing Partner Head of Credit Credit/Partners Committee Seoul
KANG, Shin Woo
Executive Managing Partner Chief Operating Officer Partners Committee Seoul
KONG, Wonpyo
Managing Partner Head of Operations Operations/Partners Committee Seoul
LEE, Daniel
Managing Partner Head of Growth Capital Growth Capital/Partners Committee Seoul
LEE, Do Haeng
Managing Partner Head of Strategy Strategy/Partners Committee Seoul
LEE, Hanju
Managing Partner Growth Capital/Partners Committee Seoul
LEE, Hyukjin
Managing Partner Private Equity/Partners Committee Seoul
LEE, Joonho
Managing Partner Head of Risk Management/ESG Risk Management/ESG/Partners Committee Seoul
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 BreezeBio | Series B | — | Feb 2026 |
| BBreeze Bio | Series B | $60M | Jan 2026 |
 XCENA | Series B | $135M | Jan 2026 |
 Liner | Series C | $36.1M | Jan 2026 |
 Portrai | Series B | — | Dec 2025 |
 Pinetree Therapeutics, Inc. | Series B | $47M | Oct 2025 |
 LIG Nex1 | Series B | — | Jul 2025 |
| DDreamAce | Unknown | $1.5M | Mar 2025 |
 MetisX | Series A | $44M | Aug 2024 |
| Pinetree Therapeutics, Inc. | Series A | $17M | Jul 2024 |
 Nota | Series C | $19.9M | Jun 2024 |
| MetisX | Series A | $44M | May 2024 |
 Zeno Health | Series C | $25M | Mar 2024 |
 PRENEU | Ipo | — | Jan 2024 |
 QSIMplus | Series A | — | Jan 2024 |
| Liner | Series C | $36.1M | Jan 2024 |
 Robros | Unknown | — | Jan 2023 |
 Virtual Internships | Series A | $14.3M | Sep 2022 |
| CCarrot General Insurance | Growth | $250M | Sep 2022 |
 AutoCrypt | Series B | $25.5M | May 2022 |
 Biorchestra | Series C | $45M | Feb 2022 |
 Neosapience, Inc. | Series B | $21.5M | Feb 2022 |
 PiLab Technology | Unknown | $8.4M | Feb 2022 |
| PPiLab technology | Series A | $8.4M | Feb 2022 |
 Tiki | Series E | $258M | Jan 2022 |
Top Co-Investors
Last updated: 7 October 2026